finance.foundation / Companies / LLY vs AZN
Comparison · seed-0.6 · 2026-08-29
Eli Lilly (LLY) vs AstraZeneca (AZN)
Eli Lilly (LLY) and AstraZeneca (AZN) side by side: both in Healthcare, listed on New York Stock Exchange and London Stock Exchange. Eli Lilly is the larger of the two by approximate market capitalization (about 3.3×).
| Field | Eli Lilly | AstraZeneca |
|---|---|---|
| Legal name | Eli Lilly and Company | AstraZeneca PLC |
| Ticker | LLY | AZN |
| Exchange | New York Stock Exchange XNYS | London Stock Exchange XLON |
| Jurisdiction | United States | United Kingdom |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Market cap ≈ | $750bn | $230bn |
| Founded | 1876 | 1999 |
| Reporting currency | USD | GBP |
| LEI | FRDRIPF3EKNDJ2CQJL29 | PY6ZZQWO2IZFZC3IOL08 |
| ISIN | US5324571083 | GB0009895292 |
| FIGI | BBG001S5STL8 | BBG001SCNW31 |
| Index membership | S&P 500 | FTSE 100 |
| Held by (covered funds) | 1 | — |
Eli Lilly
Pharmaceutical maker; GLP-1 metabolic drugs (Mounjaro, Zepbound), oncology and neuroscience.
AstraZeneca
Anglo-Swedish pharmaceutical company formed by the 1999 merger of Astra AB and Zeneca Group, with major franchises in oncology, cardiovascular and rare diseases. One of the largest companies on the London Stock Exchange.
Approximate reference values (seed-0.6 · 2026-08-29) — not real-time, not investment advice. Both sides as data: /api/v1/companies/eli-lilly · /api/v1/companies/astrazeneca